A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.60424

Publication URI: https://www.repository.cam.ac.uk/handle/1810/313318

Type: Journal Article/Review

Volume: 24

Parent Publication: Trials

Issue: 1